NCT05451173 2023-10-03
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
Xuanwu Hospital, Beijing
Phase 1/2 Unknown
Clinical Trials
8 trialsNCT06040177 2023-09-15
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Phase 1/2 Unknown
NCT05915481 2023-06-23
SCARCE
Peking University Third Hospital
Phase 1/2 Unknown
NCT05641233 2022-12-07
FIBROPANC-1
Erasmus Medical Center
Phase 1/2 Unknown
NCT05265650 2022-07-19
Noelia
Clinica Universidad de Navarra, Universidad de Navarra
Phase 1/2 Unknown
NCT02563691 2022-03-08
CROP
Sunnybrook Health Sciences Centre
Phase 1/2 Unknown
NCT05131711 2021-11-23
CSREIG
Beijing Tiantan Hospital
Phase 1/2 Unknown
NCT03446911 2018-02-27
Combining SBRT and Immunotherapy in Early Stage NSCLC Patients Planned for Surgery
Amsterdam UMC, location VUmc
Phase 1/2 Unknown